DaVita (DVA)
(Real Time Quote from BATS)
$137.40 USD
+1.55 (1.14%)
Updated May 9, 2024 11:14 AM ET
1-Strong Buy of 5 1
A Value C Growth A Momentum A VGM
Industry / Sector Report
Industry : Medical - Outpatient and Home Healthcare
Zacks Industry Rank
Top 32% (80 out of 250)Zacks Sector Rank
Top 31% (5 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 2.86 | 1.68 | 9.99 |
Current Quarter Estimate | 2.44 | 0.69 | 57.00 |
Year Ago Quarter Estimate | 2.08 | 1.31 | 52.54 |
Next Quarter Estimate | 2.68 | 0.72 | 61.00 |
Next Year Estimate | 10.19 | 5.93 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 12.04 | 11.60 | 15.67 |
Next Year | 7.38 | 17.10 | 9.31 |
Last 5 Years | 15.50 | 6.50 | 8.10 |
Next 5 Years | 13.60 | 11.90 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 14.80 | 13.83 |
Price/Book (MRQ) | 10.52 | 2.36 |
Price/Cash Flow (MRFY) | 8.08 | 12.78 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | 6.61% | 6.38% |
Return on Equity (TTM) | 68.52% | 16.77% |
Debt to Equity (MRQ) | 7.95 | 37.50 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.